Lista de obras - Krystyna Orzechowska-Juzwenko

1,5-benzodiazepine derivatives with expected psychotropic activity

artículo científico publicado el 1 de noviembre de 1979

Acetylator phenotype in patients with allergic diseases and its clinical significance

scientific article published on 01 October 1990

Activity of acid phosphatase in blood cells and bone marrow cells in some internal diseases

artículo científico publicado el 1 de julio de 1972

Bioavailability and its significance in pharmacotherapy

artículo científico publicado el 1 de enero de 2003

CYP2D6 basic genotyping as a potential tool to improve the antiemetic efficacy of ondansetron in prophylaxis of postoperative nausea and vomiting

artículo científico publicado en 2018

CYP2D6 extensive, intermediate, and poor phenotypes and genotypes in a Polish population.

artículo científico publicado en 2002

Central action of 2-amino- and 2-amino-5-aryltetrahydropyrimidinediones-4,6

artículo científico publicado el 1 de enero de 1975

Clinical drug trials in elderly persons

artículo científico publicado el 1 de enero de 2011

Combined cytochemical studies in the diagnosis of blood diseases

artículo científico publicado el 1 de septiembre de 1971

Cytochemical evaluation of cytostatic drugs action in chronic granulocytic and lymphatic leukemia

artículo científico publicado en 1980

Cytochemical reactions of peripheral blood leukocytes in infectious mononucleosis

artículo científico publicado el 15 de septiembre de 1975

Diagnostic significance of alpha-naphtoholacetate esterase activity determination in hematology

artículo científico publicado el 1 de abril de 1973

Doxepin inhibits CYP2D6 activity in vivo.

artículo científico publicado en 2004

Effect of chronic exposure to carbon disulfide on biotransformation of phenazone in rabbits

artículo científico publicado en 1984

Effect of cytostatics administration in rats on leukocyte cytochemical markers

artículo científico publicado en 1980

Effect of tobacco smoking on phenazone pharmacokinetics

artículo científico publicado el 16 de marzo de 1981

Ethical problems of clinical drug investigations and use of placebo

artículo científico publicado el 1 de febrero de 1997

Evaluation of phenazone oxidation and sulfadimidine acetylation in patients with hematologic neoplasms

artículo científico publicado el 1 de enero de 1997

Genetic significance of determined oxidation of drugs and xenobiotics in the pathogenesis of neoplastic diseases

artículo científico publicado el 1 de enero de 1997

Genetically determined sparteine oxidation and sulfadimidine acetylation polymorphism in patients with non-occupational urinary bladder cancer

scientific article published on 01 October 1994

Genetically determined sparteine oxidation polymorphism in a Polish population

artículo científico publicado en 1994

Influence of anticancer therapy on oxidation phenotype and acetylation phenotype in patients with acute myeloblastic leukemia

artículo científico publicado en 2011

Influence of chemotherapy on some cytochemical reactions in patients with acute leukemia

scientific article published on 01 January 1980

Interactions between drugs and results of laboratory tests

scientific article published on 01 September 2000

Metabolic efficiency of the liver in patients with breast cancer as determined by pharmacokinetics of phenazone

artículo científico publicado en 1987

Metabolic functions of the liver during chemotherapy in children with acute lymphoblastic leukemia.

artículo científico publicado en 2001

Monitored pharmacotherapy and factors changing drug kinetics in the body

artículo científico publicado en 1987

Monitoring kidney function in patients with essential hypertension treated with enalapril

artículo científico publicado el 1 de enero de 1997

Monitoring methotrexate therapy in patients with rheumatoid arthritis.

artículo científico publicado en 2004

Monitoring of renal function in epileptic children and teenagers treated with valproic acid or carbamazepine in concomitant therapy with tiagabine

artículo científico publicado en 2001

Optimization of lidocaine application in tumescent local anesthesia

artículo científico publicado en 2009

Pharmacological properties of new heterocyclic derivatives of 1,5-benzodiazepine

artículo científico publicado el 1 de enero de 1983

Phenazon metabolism in children with liver diseases

artículo científico publicado el 16 de marzo de 1992

Phenazone and its value as an indicator of metabolic efficiency of the liver

artículo científico publicado en 1987

Phenazone as a marker of liver-metabolic function in patients with acute leukemia

artículo científico publicado en 1999

Phenazone pharmacokinetics as an index of hepatic metabolic efficiency

artículo científico publicado en 1988

Phenotypes of oxidation and acetylation in Alzheimer's disease--preliminary report

artículo científico publicado en 2007

Principles of modern therapy in acute leukemias

artículo científico publicado el 1 de enero de 1976

Psychological characteristics of patients with neoplasms of the hematopoietic system treated with cytostatics

artículo científico publicado en 1986

Renal function in rheumatoid arthritis patients treated with methotrexate and infliximab

artículo científico publicado en 2004

Significance of cytochemical studies in hematology

artículo científico publicado el 1 de julio de 1975

Synthesis and anticonvulsant properties of some arylsuccinate methylpyridylimides.

artículo científico publicado en 1990

Synthesis and pharmacological properties of 2,4-disubstituted 5-amino-6-pyrimidinecarboxylic acid derivatives. Part II

scientific article published on 01 July 1992

Synthesis and pharmacological properties of 2,4-disubstituted 5-amino-6-pyrimidinecarboxylic acid derivatives. Part III

scientific article published on 01 September 1995

The influence of CYP2D6 polymorphism on the antiarrhythmic efficacy of propafenone in patients with paroxysmal atrial fibrillation during 3 months propafenone prophylactic treatment.

artículo científico publicado en 2001

The influence of locally implanted high doses of gentamicin on hearing and renal function of newborns treated for acute hematogenous osteomyelitis.

artículo científico publicado en 2003

The influence of physiopathologic and genetic factors on drug biotransformation

artículo científico publicado el 1 de diciembre de 1997

The methodological and clinical aspects of the placebo effect in angina pectoris

scientific article published on 01 January 1988

Toxicity interactions and ways of reducing side effects of anticancer drugs

artículo científico publicado el 1 de enero de 1982

[Acetylation phenotype and its clinical significance]

scientific article published on 01 November 1982

[Acetylation phenotype and its significance in allergic diseases]

artículo científico publicado en 1986

[Acetylation phenotype in atopic diseases]

scientific article published on 01 July 1987

[Acetylation phenotype in glomerulonephritis and its clinical significance]

artículo científico publicado en 1987

[Adverse reactions of coumarin derivative interactions]

scientific article published on 01 September 2000

[Anticancer chemotherapy containing cisplatin in patients with lung cancer and kidney function]

scientific article published on 01 February 2002

[Biotransformation of phenazone and sulfadimidine as markers of liver metabolism of drug and xenobiotic oxidation and acetylation in women with breast cancer]

scientific article published on 01 January 1997

[Chronic renal failure as a factor modifying drug metabolism in the body]

artículo científico publicado en 1986

[Clinical pharmacology of drugs used in thromboembolism]

scientific article published on 01 December 1983

[Clinical sequelae of genetically determined polymorphisms of drug oxidation]

artículo científico publicado en 1992

[Clinical significance of disorders of drug kinetics in liver diseases]

scientific article published on 01 April 1986

[Clinical significance of oxidation and acetylation genetic polymorphism in patients with Parkinson's disease]

artículo científico publicado en 1999

[Clinical significance of oxidation and acetylation genetic polymorphism in patients with hyperthyreosis]

artículo científico publicado en 2006

[Clinical significance of the determination of oxidation and acetylation phenotype in patients with multiple sclerosis]

artículo científico publicado en 1996

[Clinical significance of the pharmacogenetics in psychiatric and neurological syndromes]

artículo científico publicado en 1996

[Comparison of the effectiveness of metoclopramide and dexamethasone in the prevention of cytostatic-induced vomiting]

scientific article published on 01 August 1990

[Contemporary concept of placebo usage in clinical trials of new drugs]

artículo científico publicado en 2007

[Disorders of pharmacokinetics in pathological states and their clinical significance]

artículo científico publicado en 1984

[Drug acetylation processes in patients with chronic renal failure treated by hemodialysis]

artículo científico publicado en 1992

[Drug interactions]

artículo científico publicado en 2000

[Effect of contamination of drinking water with sodium fluoride on the alkaline phosphatase activity of peripheral granulocytes in the rat]

artículo científico publicado en 1980

[Effect of disorders of thyroid function on phenazone pharmacokinetics]

scientific article published on 01 February 1990

[Evaluation of renal function in children undergoing surgery under general anaesthesia]

artículo científico publicado en 2002

[General principles of cancer chemotherapy]

scientific article published on 01 December 1983

[Genetically determined disorders of pharmacodynamic reaction to drugs and their clinical significance]

artículo científico publicado en 1986

[Genetically determined disorders of pharmacokinetics and their clinical significance]

scientific article published on 01 December 1984

[Importance of genetically determined acetylation of drugs and xenobiotics in pathogenesis of neoplasms]

artículo científico publicado en 1997

[Interactions of nonsteroidal anti-inflammatory drugs]

artículo científico publicado en 2000

[Monitoring of methotrexate treatment of children with proliferative diseases of the hematopoietic system]

artículo científico publicado en 1988

[N-acetyl-beta-D-glucosaminidase and its clinical significance]

scientific article published on 01 April 1999

[Occurrence of the fast acetylation phenotype in persons with the radicular syndrome. Preliminary report]

artículo científico publicado en 1987

[Optimizing pharmacotherapeutic aspects of pharmacokinetic and pharmacodynamic drug properties in the elderly]

artículo científico publicado en 1998

[Oxidation phenotype as a risk factor for development of allergic diseases]

artículo científico publicado en 1999

[Pharmacokinetics of phenazone as an indicator of the metabolic capacity of the liver in patients with hyperthyroidism]

artículo científico publicado en 1983

[Pharmacology and pharmacokinetics of propafenone]

artículo científico publicado en 1991

[Pharmacotherapy monitored by drug levels in the body]

artículo científico publicado en 1985

[Practical aspects of pharmacokinetics in renal failure]

artículo científico publicado en 1982

[Prevention of methotrexate toxicity during intensive neoplasm treatment]

artículo científico publicado en 1980

[Renal tubular dysfunction in patients with rheumatoid arthritis starting with low dose of methotrexate]

artículo científico publicado en 2003

[Significance of CYP2D6 oxidation genotype as a risk factor in development of allergic diseases]

artículo científico publicado en 2003

[The Rubenosticon test in hematologic and lymphoreticular diseases]

artículo científico publicado en 1984

[The influence of clomipramine on CYP2D6 activity]

scientific article published on 01 March 2007

[The new generation of macrolide antibiotics]

artículo científico publicado en 1998

[The role of genetically determined acetylation of drugs and xenobiotics in pathogenesis of neoplastic diseases]

scientific article published on 01 January 1996

[The role of genetically determined oxidation of drugs and xenobiotics in pathogenesis of neoplastic diseases]

artículo científico publicado en 1996

[Toxic and psychogenic causes of nausea and vomiting associated with cytostatic treatment]

[Unwanted drug interaction between anti-arrhythmic drugs and drugs used for heart failure]

scientific article published on 01 September 2000

[Vomiting accompanying cytostatic treatment, and its control]

artículo científico publicado en 1984

Lista de obras de Krystyna Orzechowska-Juzwenko

1,5-benzodiazepine derivatives with expected psychotropic activity

Acetylator phenotype in patients with allergic diseases and its clinical significance

Activity of acid phosphatase in blood cells and bone marrow cells in some internal diseases

Bioavailability and its significance in pharmacotherapy

CYP2D6 basic genotyping as a potential tool to improve the antiemetic efficacy of ondansetron in prophylaxis of postoperative nausea and vomiting

CYP2D6 extensive, intermediate, and poor phenotypes and genotypes in a Polish population.

Central action of 2-amino- and 2-amino-5-aryltetrahydropyrimidinediones-4,6

Clinical drug trials in elderly persons

Combined cytochemical studies in the diagnosis of blood diseases

Cytochemical evaluation of cytostatic drugs action in chronic granulocytic and lymphatic leukemia

Cytochemical reactions of peripheral blood leukocytes in infectious mononucleosis

Diagnostic significance of alpha-naphtoholacetate esterase activity determination in hematology

Doxepin inhibits CYP2D6 activity in vivo.

Effect of chronic exposure to carbon disulfide on biotransformation of phenazone in rabbits

Effect of cytostatics administration in rats on leukocyte cytochemical markers

Effect of tobacco smoking on phenazone pharmacokinetics

Ethical problems of clinical drug investigations and use of placebo

Evaluation of phenazone oxidation and sulfadimidine acetylation in patients with hematologic neoplasms

Genetic significance of determined oxidation of drugs and xenobiotics in the pathogenesis of neoplastic diseases

Genetically determined sparteine oxidation and sulfadimidine acetylation polymorphism in patients with non-occupational urinary bladder cancer

Genetically determined sparteine oxidation polymorphism in a Polish population

Influence of anticancer therapy on oxidation phenotype and acetylation phenotype in patients with acute myeloblastic leukemia

Influence of chemotherapy on some cytochemical reactions in patients with acute leukemia

Interactions between drugs and results of laboratory tests

Metabolic efficiency of the liver in patients with breast cancer as determined by pharmacokinetics of phenazone

Metabolic functions of the liver during chemotherapy in children with acute lymphoblastic leukemia.

Monitored pharmacotherapy and factors changing drug kinetics in the body

Monitoring kidney function in patients with essential hypertension treated with enalapril

Monitoring methotrexate therapy in patients with rheumatoid arthritis.

Monitoring of renal function in epileptic children and teenagers treated with valproic acid or carbamazepine in concomitant therapy with tiagabine

Optimization of lidocaine application in tumescent local anesthesia

Pharmacological properties of new heterocyclic derivatives of 1,5-benzodiazepine

Phenazon metabolism in children with liver diseases

Phenazone and its value as an indicator of metabolic efficiency of the liver

Phenazone as a marker of liver-metabolic function in patients with acute leukemia

Phenazone pharmacokinetics as an index of hepatic metabolic efficiency

Phenotypes of oxidation and acetylation in Alzheimer's disease--preliminary report

Principles of modern therapy in acute leukemias

Psychological characteristics of patients with neoplasms of the hematopoietic system treated with cytostatics

Renal function in rheumatoid arthritis patients treated with methotrexate and infliximab

Significance of cytochemical studies in hematology

Synthesis and anticonvulsant properties of some arylsuccinate methylpyridylimides.

Synthesis and pharmacological properties of 2,4-disubstituted 5-amino-6-pyrimidinecarboxylic acid derivatives. Part II

Synthesis and pharmacological properties of 2,4-disubstituted 5-amino-6-pyrimidinecarboxylic acid derivatives. Part III

The influence of CYP2D6 polymorphism on the antiarrhythmic efficacy of propafenone in patients with paroxysmal atrial fibrillation during 3 months propafenone prophylactic treatment.

The influence of locally implanted high doses of gentamicin on hearing and renal function of newborns treated for acute hematogenous osteomyelitis.

The influence of physiopathologic and genetic factors on drug biotransformation

The methodological and clinical aspects of the placebo effect in angina pectoris

Toxicity interactions and ways of reducing side effects of anticancer drugs

[Acetylation phenotype and its clinical significance]

[Acetylation phenotype and its significance in allergic diseases]

[Acetylation phenotype in atopic diseases]

[Acetylation phenotype in glomerulonephritis and its clinical significance]

[Adverse reactions of coumarin derivative interactions]

[Anticancer chemotherapy containing cisplatin in patients with lung cancer and kidney function]

[Biotransformation of phenazone and sulfadimidine as markers of liver metabolism of drug and xenobiotic oxidation and acetylation in women with breast cancer]

[Chronic renal failure as a factor modifying drug metabolism in the body]

[Clinical pharmacology of drugs used in thromboembolism]

[Clinical sequelae of genetically determined polymorphisms of drug oxidation]

[Clinical significance of disorders of drug kinetics in liver diseases]

[Clinical significance of oxidation and acetylation genetic polymorphism in patients with Parkinson's disease]

[Clinical significance of oxidation and acetylation genetic polymorphism in patients with hyperthyreosis]

[Clinical significance of the determination of oxidation and acetylation phenotype in patients with multiple sclerosis]

[Clinical significance of the pharmacogenetics in psychiatric and neurological syndromes]

[Comparison of the effectiveness of metoclopramide and dexamethasone in the prevention of cytostatic-induced vomiting]

[Contemporary concept of placebo usage in clinical trials of new drugs]

[Disorders of pharmacokinetics in pathological states and their clinical significance]

[Drug acetylation processes in patients with chronic renal failure treated by hemodialysis]

[Drug interactions]

[Effect of contamination of drinking water with sodium fluoride on the alkaline phosphatase activity of peripheral granulocytes in the rat]

[Effect of disorders of thyroid function on phenazone pharmacokinetics]

[Evaluation of renal function in children undergoing surgery under general anaesthesia]

[General principles of cancer chemotherapy]

[Genetically determined disorders of pharmacodynamic reaction to drugs and their clinical significance]

[Genetically determined disorders of pharmacokinetics and their clinical significance]

[Importance of genetically determined acetylation of drugs and xenobiotics in pathogenesis of neoplasms]

[Interactions of nonsteroidal anti-inflammatory drugs]

[Monitoring of methotrexate treatment of children with proliferative diseases of the hematopoietic system]

[N-acetyl-beta-D-glucosaminidase and its clinical significance]